Human-on-a-Chip: Future clinical drug trials may stop relying on humans altogether

Screen Shot at AM

Disasters [in human drug trials] are rare. But also rare are clinical trials that go well: Ninety percent of drugs tested on humans do not work. These failures are an expensive but necessary part of the estimated $2.6 billion it costs to bring a medicine to market.

A lab in California is working on a more efficient and humane process, based on a quarter-size plastic slide. It’s a tiny replica of the human brain, rendered in clusters of about 300,000 cells surrounded by small copper wires. Based on that, Lawrence Livermore ­National Lab (LLNL) researchers have set out to build a comprehensive human body in miniature. Called the iChip, it could be the future of drug testing.

How iCHIP will test different aspects of a target drug. Credit: The Newsstack
How iCHIP will test different aspects of a target drug. Credit: The Newsstack

“Most people aren’t really thrilled with us injecting anything new into a human,” says Heather Enright, an iChip researcher. But testing drugs on animals instead provides limited information. For example, tumors develop differently in mice than they do in humans. With iChip, a dose of a new medication could be injected into the cells of a mini organ, and researchers could monitor the effects without harming live subjects.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: How to Conduct Human Drug Trials Without Needing Any Pesky Humans

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...

Most Popular

News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend